ctrl K

Watchlist Price Alert

Rubius Therapeutics Inc. (RUBY)

NASDAQ: RUBY · Real-Time Price · USD

0.06

0.00 (8.11%)

At close: Dec 29, 2023, 8:49 PM

Rubius Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-178.45M	-194.62M	-166.45M	-169.6M	-91.66M	-43.26M	-10.85M
Interest Income	819K	91K	1.76M	7.99M	5.12M	511K	-16K
Pretax Income	-179.67M	-196.55M	-167.73M	-163.46M	-89.19M	-43.85M	-11.02M
Net Income	-230.86M	-188.82M	-162.04M	-160.46M	-89.19M	-43.85M	-11.02M
Selling & General & Admin	30.84M	53.03M	50.34M	57.18M	39.89M	22.04M	2.45M
Research & Development	96.41M	141.59M	116.11M	112.42M	51.77M	21.23M	8.4M
Other Expenses	1.82M	-1.93M	-1.28M	6.14M	2.47M	-785K	-16K
Operating Expenses	127.25M	194.62M	166.45M	169.6M	91.66M	43.26M	10.85M
Interest Expense	3.86M	6.43M	4.18M	2.59M	464K	309K	149K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	127.25M	194.62M	166.45M	169.6M	91.66M	43.26M	10.85M
Income Tax Expense	51.2M	-7.72M	-5.69M	-3M	2.93M	309K	133K
Shares Outstanding (Basic)	90.31M	87.95M	80.62M	78.69M	39.29M	8.54M	8.54M
Shares Outstanding (Diluted)	90.31M	87.95M	80.62M	78.69M	39.29M	8.54M	8.54M
EPS (Basic)	-2.56	-2.15	-2.01	-2.04	-2.27	-5.13	-1.29
EPS (Diluted)	-2.56	-2.15	-2.01	-2.04	-2.27	-5.13	-1.29
EBITDA	-118.35M	-194.62M	-166.45M	-169.6M	-91.66M	-42.31M	-10.75M
EBIT	-175.8M	-190.11M	-163.55M	-160.87M	-88.73M	-43.74M	-10.72M
Depreciation & Amortization	6.25M	7.72M	5.69M	3M	1.26M	447K	118K